Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0752347 (
Dementia with Lewy bodies
)
1,653
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We investigated whether bcl-2 protein family is involved in the pathogenesis of the dopaminergic neurodegeneration that occurs in
Dementia with Lewy bodies
(
DLB
). The expression of the proapoptotic protein bax and the antiapoptotic proteins bcl-2 and
bcl-xL
was investigated by Western blot in the pars compacta of the substantia nigra of pure and common
DLB
forms. No changes in the nigral expression levels of bax, bcl-2 and
bcl-xL
proteins were found between control and
DLB
pure cases. In the common
DLB
forms, nigral
bcl-xL
and bcl-2 proteins levels were significantly decreased in the
DLB
cases associated with a concomitant severe AD pathology (p < 0.05). An increase in nigral bcl-2 protein expression was observed in the
DLB
cases with a mild AD-associated pathology (p < 0.05). The present results are in agreement with previous observations indicating that
DLB
cases with severe AD pathology tend to show severe Lewy pathology suggesting that AD pathology might exacerbate Lewy pathology.
...
PMID:Differential nigral expression of bcl-2 protein family in the pure and common forms of Dementia with Lewy bodies: relevance for dopaminergic neuronal vulnerability. 1764 17